Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Humberstone

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
Pharmatherapeutica|January 1, 1984
Fenoterol plus ipratropium ('Duovent') aerosol therapy delivered by a tube spacerA Woodcock, A Humberstone, B Sutton, et al.
Human Reproduction (Oxford, England)|February 3, 2021
Effect of the oxytocin receptor antagonist nolasiban on pregnancy rates in women undergoing embryo transfer following IVF: analysis of three randomised clinical trialsG Griesinger, C Blockeel, P Pierzynski, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 9, 2025
Efficacy and safety of ebopiprant to delay preterm birth after oral administration in pregnant women with spontaneous preterm labor receiving atosiban: a phase 2a, double-blind, parallel group, randomized, placebo-controlled, proof of concept studyB W Mol, I Fatkullin, L Islamova, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
Pharmatherapeutica|January 1, 1984
Fenoterol plus ipratropium ('Duovent') aerosol therapy delivered by a tube spacerA Woodcock, A Humberstone, B Sutton, et al.
Human Reproduction (Oxford, England)|February 3, 2021
Effect of the oxytocin receptor antagonist nolasiban on pregnancy rates in women undergoing embryo transfer following IVF: analysis of three randomised clinical trialsG Griesinger, C Blockeel, P Pierzynski, et al.
European Journal of Obstetrics, Gynecology, and Reproductive Biology|August 9, 2025
Efficacy and safety of ebopiprant to delay preterm birth after oral administration in pregnant women with spontaneous preterm labor receiving atosiban: a phase 2a, double-blind, parallel group, randomized, placebo-controlled, proof of concept studyB W Mol, I Fatkullin, L Islamova, et al.
Pageof 2